Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Trials underway for new cattle vaccine and bTB skin test
More than 36,000 cattle in England and Wales were culled in the last year in a bid to tackle bTB.
Chief vets state that a working vaccine could be deployed by 2025.
 
Groundbreaking field trials are underway in England for a cattle vaccine and a new skin test for bovine tuberculosis (bTB), the Animal and Plant Health Agency has announced (APHA).

Scientists hope that the vaccine will bring vets and farmers a step closer to protect their animals against the disease, helping to save thousands of cattle every year that would have otherwise been culled.

The accompanying skin test also represents a major breakthrough, by allowing vets to identify cattle that have been vaccinated and those that are infected with the disease.

In a joint statement, the UK’s Chief Veterinary Officers said that, if the trials completed successfully, then a working cattle vaccine could be deployed by 2025:

“Bovine Tuberculosis represents one of the most difficult animal disease challenges we face today. However, the start of these ground-breaking field trials will be welcome news for many farmers who have been greatly impacted by this disease and represents an important step forward in our efforts to deploy a working cattle vaccine by 2025.

“If successful, the world-leading project could lead to the first-ever deployment of a cattle bTB vaccine and DIVA skin test and will be instrumental in turning the tide against this terrible disease which impacts many countries around the world.”

More than 36,000 cattle in England and Wales have culled in the last year in a bid to tackle bTB, at a cost of around £100 million to the taxpayer. 

But the Badger Trust - which has long campaigned for serious investment in a cattle vaccine - states that some 140,000 badgers have also been slaughtered since 2013, when the lethal culling of badgers became the primary control method in England.

Dawn Varley, acting CEO of the Badger Trust, cautiously welcomed the trials, adding: 'Whilst we welcome the pilot and talk of a hoped-for roll out by 2025, this news is too little, too late for the badgers already lost to years of misguided culling.

“With 140,000 badgers killed since 2013, and with culling set to continue to 2025 as confirmed by the Government earlier this year, we estimate another 140,000 badgers are still to be shot to control what is primarily a cattle spread disease.

“We've been calling for serious investment in a cattle vaccine for over 10 years. bTB is a cattle disease, spread by cattle to cattle, and primarily through cattle movements from farm to farm. It's only by addressing the disease in cattle that the battle will be won.”

The first phase of the trials is taking place at a bTB-free farm in Hertfordshire to ascertain the accuracy and safety of the DIVA skin test, with more herds across England and Wales to join them over the coming months.

If successful, the study will then expand to more farms in England and Wales to test both the Cattle BCG vaccine and DIVA skin test together.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."